These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 32385713)

  • 1. Wnts and the hallmarks of cancer.
    Zhong Z; Yu J; Virshup DM; Madan B
    Cancer Metastasis Rev; 2020 Sep; 39(3):625-645. PubMed ID: 32385713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt Signaling and Drug Resistance in Cancer.
    Zhong Z; Virshup DM
    Mol Pharmacol; 2020 Feb; 97(2):72-89. PubMed ID: 31787618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Wnt pathway and the roles for its antagonists, DKKS, in angiogenesis.
    Choi HJ; Park H; Lee HW; Kwon YG
    IUBMB Life; 2012 Sep; 64(9):724-31. PubMed ID: 22807036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of noncanonical Wnt signaling in cancers.
    Chen Y; Chen Z; Tang Y; Xiao Q
    Biomed Pharmacother; 2021 Jan; 133():110946. PubMed ID: 33212376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wnts of change: How Wnts regulate phenotype switching in melanoma.
    Webster MR; Kugel CH; Weeraratna AT
    Biochim Biophys Acta; 2015 Dec; 1856(2):244-51. PubMed ID: 26546268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WIF1 can effectively co-regulate pro-apoptotic activity through the combination with DKK1.
    Ko YB; Kim BR; Yoon K; Choi EK; Seo SH; Lee Y; Lee MA; Yang JB; Park MS; Rho SB
    Cell Signal; 2014 Nov; 26(11):2562-72. PubMed ID: 25086206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into the role of Wnt5a-induced signaling in normal and cancer cells.
    Endo M; Nishita M; Fujii M; Minami Y
    Int Rev Cell Mol Biol; 2015; 314():117-48. PubMed ID: 25619716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy.
    Dzobo K; Thomford NE; Senthebane DA
    OMICS; 2019 Nov; 23(11):517-538. PubMed ID: 31613700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer.
    Cui J; Jiang W; Wang S; Wang L; Xie K
    Curr Pharm Des; 2012; 18(17):2464-71. PubMed ID: 22372504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the tumor stroma in cancer therapy.
    Anton K; Glod J
    Curr Pharm Biotechnol; 2009 Feb; 10(2):185-91. PubMed ID: 19199950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of tumor angiogenesis and metastasis through modulation of cell redox state.
    Serrano JJ; Delgado B; Medina MÁ
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188352. PubMed ID: 32035101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
    Prosperi JR; Goss KH
    Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncanonical Wnt signaling in tumor progression and metastasis.
    Jessen JR
    Zebrafish; 2009 Mar; 6(1):21-8. PubMed ID: 19292672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNT signaling: an emerging mediator of cancer cell metabolism?
    Sherwood V
    Mol Cell Biol; 2015 Jan; 35(1):2-10. PubMed ID: 25348713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Wnt/β-catenin signaling pathway in cancer.
    Zhang Y; Wang X
    J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the canonical Wnt/β-catenin pathway in cancer radioresistance: Updates on the molecular mechanisms.
    Yang Y; Zhou H; Zhang G; Xue X
    J Cancer Res Ther; 2019; 15(2):272-277. PubMed ID: 30964097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Wnt Signaling Landscape of Mammary Stem Cells and Breast Tumors.
    Alexander CM
    Prog Mol Biol Transl Sci; 2018 Jan; 153():271-298. PubMed ID: 29389520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological interventions in the Wnt pathway: inhibition of Wnt secretion versus disrupting the protein-protein interfaces of nuclear factors.
    Zimmerli D; Hausmann G; Cantù C; Basler K
    Br J Pharmacol; 2017 Dec; 174(24):4600-4610. PubMed ID: 28521071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/β-catenin signaling pathway.
    Fang Y; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    Cancer Biomark; 2018; 23(3):405-418. PubMed ID: 30223390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt5a promotes vasculogenic mimicry and epithelial-mesenchymal transition via protein kinase Cα in epithelial ovarian cancer.
    Qi H; Sun B; Zhao X; Du J; Gu Q; Liu Y; Cheng R; Dong X
    Oncol Rep; 2014 Aug; 32(2):771-9. PubMed ID: 24898696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.